Collier Kathryn J — SEC Form 4 filings
SEC reporting owner CIK 1737436. 6 Form 4 filings on record with FilingPulse; latest filed 2025-06-27.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-05-17 to 2025-06-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 4,000 shares, $7,280 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: purchase of 4,000 shares @ $1.82 ($7,280) in Regulus Therapeutics Inc., filed 2024-07-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Regulus Therapeutics Inc. (RGLS) | Director | 6 | 1 leg · 4,000 sh · $7,280 | — | 16 |
Form 4 filings — Collier Kathryn J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-06-27 | 4 | Regulus Therapeutics Inc. (RGLS) | Disposition to issuer (D): 75,565 · Disposition to issuer (D): 4,650 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +1 more | EDGAR |
| 2025-06-18 | 4 | Regulus Therapeutics Inc. (RGLS) | Option exercise (M): 1,396 @ $9.90 · Option exercise (M): 2,604 @ $9.90 · Option exercise (M): 2,325 @ $8.80 · Option exercise (M): 1,396 (derivative) @ $0 · Option exercise (M): 2,604 (derivative) @ $0 · Option exercise (M): 2,325 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | Regulus Therapeutics Inc. (RGLS) | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2024-07-29 | 4 | Regulus Therapeutics Inc. (RGLS) | Purchase (P): 4,000 @ $1.82 | EDGAR |
| 2024-05-21 | 4 | Regulus Therapeutics Inc. (RGLS) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Regulus Therapeutics Inc. (RGLS) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1737436 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →